Gt Biopharma Stock Price History

Below is the normalized historical share price chart for GT Biopharma extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of GT Biopharma stands at 2.40, as last reported on the 18th of March 2025, with the highest price reaching 2.55 and the lowest price hitting 2.40 during the day. If you're considering investing in GTBP Stock, it is important to understand the factors that can impact its price. GT Biopharma appears to be very risky, given 3 months investment horizon. GT Biopharma retains Efficiency (Sharpe Ratio) of 0.0665, which attests that the entity had a 0.0665 % return per unit of price deviation over the last 3 months. By inspecting GT Biopharma's technical indicators, you can evaluate if the expected return of 0.65% is justified by implied risk. Please utilize GT Biopharma's Market Risk Adjusted Performance of 0.2721, semi deviation of 6.11, and Standard Deviation of 9.75 to validate if our risk estimates are consistent with your expectations. At this time, GT Biopharma's Other Stockholder Equity is relatively stable compared to the past year. As of 03/18/2025, Stock Based Compensation To Revenue is likely to grow to 131.64, though Total Stockholder Equity is likely to grow to (1.6 M). . As of 03/18/2025, Price To Sales Ratio is likely to drop to 2,293. In addition to that, Price Earnings Ratio is likely to grow to -0.42. GTBP Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0665

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns				GTBP
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return